1. accedaCRIS
  2. Publicaciones
  3. Artículos
Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/handle/10553/136274
DC FieldValueLanguage
dc.contributor.authorde Bock, Martin-
dc.contributor.authorAgwu, Juliana Chizo-
dc.contributor.authorDeabreu, Matt-
dc.contributor.authorDovc, Klemen-
dc.contributor.authorMaahs, David M.-
dc.contributor.authorMarcovecchio, M. Loredana-
dc.contributor.authorMahmud, Farid H.-
dc.contributor.authorNovoa Medina, Yeray-
dc.contributor.authorPriyambada, Leena-
dc.contributor.authorSmart, Carmel E.-
dc.contributor.authorDimeglio, Linda A.-
dc.date.accessioned2025-02-17T16:12:02Z-
dc.date.available2025-02-17T16:12:02Z-
dc.date.issued2024-
dc.identifier.issn1663-2818-
dc.identifier.otherWoS-
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/136274-
dc.description.abstractThe International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines represent a rich repository that serves as the only comprehensive set of clinical recommendations for children, adolescents, and young adults living with diabetes worldwide. This chapter builds on the 2022 ISPAD guidelines, and updates recommendations on the glycemic targets for children and adolescents living with diabetes. A new target for hemoglobin A1c (HbA1c) of <= 6.5% (48 mmol/mol) is recommended for those who have access to advanced diabetes technologies like continuous glucose monitoring and automated insulin delivery. This target should be encouraged for all children and adolescents living with diabetes when safely achievable. In other settings, the HbA1c target is <= 7.0% (53 mmol/mol).-
dc.languagespa-
dc.relation.ispartofHormone Research In Paediatrics-
dc.sourceHormone Research In Paediatrics[ISSN 1663-2818],v. 97 (6), p. 546-554, (Diciembre 2024)-
dc.subject32 Ciencias médicas-
dc.subject320502 Endocrinología-
dc.subject.otherRisk-Factors-
dc.subject.otherTight-Range-
dc.subject.otherType-1-
dc.subject.otherManagement-
dc.subject.otherChildren-
dc.subject.otherTime-
dc.subject.otherRetinopathy-
dc.subject.otherHba(1C)-
dc.subject.otherObesity-
dc.subject.otherGlycemic Targets-
dc.subject.otherTechnology-
dc.subject.otherBurden-
dc.subject.otherDiabetes-Related Complications-
dc.titleInternational Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets-
dc.typeinfo:eu-repo/semantics/Article-
dc.typeArticle-
dc.identifier.doi10.1159/000543266-
dc.identifier.scopus85217972003-
dc.identifier.isi001415460300001-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcid0000-0001-9201-2145-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.orcidNO DATA-
dc.contributor.authorscopusid48261109100-
dc.contributor.authorscopusid6507060190-
dc.contributor.authorscopusid58024177800-
dc.contributor.authorscopusid55992904400-
dc.contributor.authorscopusid6506108916-
dc.contributor.authorscopusid9243301200-
dc.contributor.authorscopusid13807128900-
dc.contributor.authorscopusid33568100400-
dc.contributor.authorscopusid35786427300-
dc.contributor.authorscopusid15023496200-
dc.contributor.authorscopusid58707839200-
dc.identifier.eissn1663-2826-
dc.description.lastpage554-
dc.identifier.issue6-
dc.description.firstpage546-
dc.relation.volume97-
dc.investigacionCiencias de la Salud-
dc.type2Artículo-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.contributor.daisngidNo ID-
dc.description.numberofpages9-
dc.utils.revisionSí-
dc.contributor.wosstandardWOS:de Bock, M-
dc.contributor.wosstandardWOS:Agwu, JC-
dc.contributor.wosstandardWOS:Deabreu, M-
dc.contributor.wosstandardWOS:Dovc, K-
dc.contributor.wosstandardWOS:Maahs, DM-
dc.contributor.wosstandardWOS:Marcovecchio, ML-
dc.contributor.wosstandardWOS:Mahmud, FH-
dc.contributor.wosstandardWOS:Nóvoa-Medina, Y-
dc.contributor.wosstandardWOS:Priyambada, L-
dc.contributor.wosstandardWOS:Smart, CE-
dc.contributor.wosstandardWOS:Dimeglio, LA-
dc.date.coverdateDiciembre 2024-
dc.identifier.ulpgcSí-
dc.contributor.buulpgcBU-MED-
item.fulltextCon texto completo-
item.grantfulltextopen-
crisitem.author.deptGIR IUIBS: Diabetes y endocrinología aplicada-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0002-9564-0654-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNovoa Medina, Yeray-
Appears in Collections:Artículos
Adobe PDF (331,95 kB)
Show simple item record

WEB OF SCIENCETM
Citations

3
checked on Jun 8, 2025

Google ScholarTM

Check

Altmetric


Share


Export metadata


Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.